Lv71
4600 积分 2020-12-17 加入
M9657 Is a Bispecific Tumor-Targeted Anti-CD137 Agonist That Induces MSLN-Dependent Antitumor Immunity without Liver Inflammation
27天前
已完结
Safety and Pharmacokinetic Assessment of the FIC CLDN18.2/4-1BB Bispecific Antibody in Rhesus Monkeys
29天前
已完结
Preclinical efficacy and pharmacokinetics of an RNA-encoded T cell–engaging bispecific antibody targeting human claudin 6
1个月前
已完结
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
2个月前
已完结
Pancreas-targeted lipid nanoparticles for relatively non-invasive interleukin-12 mRNA therapy in orthotopic pancreatic ductal adenocarcinoma
3个月前
已完结
Extracellular targeted protein degrader removes antibodies in first test in humans
5个月前
已完结
Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics
5个月前
已完结
Roadmap for Optimizing and Broadening Antibody-Based PROTACs for Degradation of Cell Surface Proteins
5个月前
已完结
Targeted Protein Degradation via Lysosomes
5个月前
已完结
Research progress on asialoglycoprotein receptor-targeted radiotracers designed for hepatic nuclear medicine imaging
6个月前
已完结
皖公网安备34019202002308
